Aim to list Biocon Biologics on capital markets by 2023: CFO MB Chinappa

Aim to list Biocon Biologics on capital markets by 2023: CFO MB Chinappa Biocon Biologics has raised $105 million so far this calendar year through two primary equity infusions.

No comments:

Post a Comment